Altimmune, Inc.
ALT
$3.47
$0.051.32%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 7.33% | 18.94% | 13.42% | 2.72% | -7.48% |
| Total Depreciation and Amortization | -52.94% | -62.70% | 147.78% | 119.14% | 129.10% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30.48% | -47.53% | -54.89% | -49.91% | -51.70% |
| Change in Net Operating Assets | 50.78% | 97.46% | -159.67% | 0.00% | 154.12% |
| Cash from Operations | 15.42% | 15.06% | -14.11% | -10.41% | -5.33% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -366.65% | 20.62% | 336.98% | 115.43% | -306.01% |
| Cash from Investing | -366.68% | 20.60% | 336.96% | 115.44% | -306.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,497.81% | 66.45% | 12.43% | -47.81% | -87.48% |
| Repurchase of Common Stock | 16.59% | 22.49% | 21.86% | 18.53% | 16.99% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -182.24% | -- |
| Cash from Financing | 1,959.36% | 86.76% | 32.42% | -48.43% | -88.34% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 106.96% | 153.74% | 378.56% | -16.21% | -508.67% |